ClinicalTrials.Veeva

Menu

Lacosamide in Neonatal Status Epilepticus

S

Sherief Abd-Elsalam

Status and phase

Unknown
Phase 3

Conditions

Epilepsy

Treatments

Drug: Phenobarbital
Drug: Lacosamide

Study type

Interventional

Funder types

Other

Identifiers

NCT05291455
abeer ped neurology

Details and patient eligibility

About

Lacosamide in neonatal status epilepticus

Full description

The study will assess the efficacy of Lacosamide in neonatal status epilepticus

Enrollment

60 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • neonates with status epilepticus

Exclusion criteria

  • congenital anomalies or organ dysfunction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Lacosamide
Experimental group
Description:
Lacosamide will be given.
Treatment:
Drug: Lacosamide
Phenobarbitone
Active Comparator group
Description:
Phenobarbital will be given
Treatment:
Drug: Phenobarbital

Trial contacts and locations

1

Loading...

Central trial contact

abeer salamah, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems